4-(3-Fluorophenoxy)-6-piperidin-3-yl-2-pyridin-4-ylpyrimidine

ID: ALA3637828

Chembl Id: CHEMBL3637828

PubChem CID: 46958202

Max Phase: Preclinical

Molecular Formula: C20H19FN4O

Molecular Weight: 350.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1cccc(Oc2cc(C3CCCNC3)nc(-c3ccncc3)n2)c1

Standard InChI:  InChI=1S/C20H19FN4O/c21-16-4-1-5-17(11-16)26-19-12-18(15-3-2-8-23-13-15)24-20(25-19)14-6-9-22-10-7-14/h1,4-7,9-12,15,23H,2-3,8,13H2

Standard InChI Key:  ZJGVYQXYGBOOLQ-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis H37Rv (422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis variant bovis (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.40Molecular Weight (Monoisotopic): 350.1543AlogP: 3.94#Rotatable Bonds: 4
Polar Surface Area: 59.93Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.60CX LogP: 3.76CX LogD: 1.58
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.77Np Likeness Score: -1.42

References

1. Rebollo-Lopez, M. J.; Lelièvre, J.; Alvarez-Gomez, D.; Castro-Pichel, J.; Martínez-Jiménez, F.; Papadatos, G.; Kumar, V.; Colmenarejo, G.; Mugumbate, G.; Hurle, M.; Barroso, V.; Young, R. J.; Martinez-Hoyos, M.; González del Río, R.; Bates, R. H.; Lopez-Roman, E. M.; Mendoza-Losana, A.; Brown, J. R.; Alvarez-Ruiz, E.; Marti-Renom, M. A.; Overington, J. P.; Cammack, N.; Ballell, L.; Barros-Aguire, D., . GSK Tres Cantos Follow-up TB Screening Data.,  [10.6019/CHEMBL3637782]

Source